Press release
Glycated Haemoglobin Testing Market Surges to USD 3.10 Billion by 2030, growing at a CAGR of 9.2%.
Glycated Haemoglobin Testing Market
Sub-Headline: Rising diabetes prevalence, rapid adoption of point-of-care devices, and technological advancements in HbA1c analyzers are pushing the global market from USD 1.65 billion in 2023 to USD 3.10 billion by 2030, growing at a CAGR of 9.2%.
Introduction
The Glycated Haemoglobin (HbA1c) Testing Market is witnessing strong global momentum as diabetes continues to grow at an alarming rate across developed and developing nations. HbA1c testing-considered the gold standard for long-term glycemic monitoring-has become indispensable for managing Type 1 and Type 2 diabetes. With more healthcare systems adopting early diagnostic protocols and point-of-care (POC) solutions, the market is poised for significant expansion through 2030.
This press release highlights market size, growth dynamics, key players, segment insights, major innovations, and future opportunities shaping the industry.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/73489
Key Takeaways
• Market Size (2023): USD 1.65 Billion
• Expected Market Size (2030): USD 3.10 Billion
• CAGR (2024-2030): 9.2%
• Growth driven by rising diabetes prevalence, aging population, and shift toward home-based monitoring.
• Leading companies: Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Bio-Rad Laboratories, Danaher Corporation, Trividia Health, ARKRAY, Tosoh Corporation, and others.
• Point-of-care HbA1c testing is the fastest-growing segment due to decentralization of diabetes care.
Market Story
With diabetes now affecting over 540 million adults globally, the need for consistent glycemic monitoring has never been higher. HbA1c testing, which reflects three-month average blood glucose levels, is crucial for diagnosis, treatment decisions, and long-term monitoring.
Technological advancements such as miniaturized analyzers, AI-driven accuracy improvements, automated lab systems, and digital data integration have transformed both clinical and home-care diabetes management. POC devices are becoming increasingly popular, particularly in primary care clinics, rural health centers, emergency setups, and pharmacies, where immediate results improve clinical decision-making.
Healthcare infrastructure expansion across India, China, Southeast Asia, Africa, and Latin America is dramatically increasing testing demand. Growing government screening programs and insurance reimbursements are enhancing test accessibility.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/73489/glycated-haemoglobin-testing-market
Market Segments
By Type
• Lab-based HbA1c Testing (largest revenue contributor, preferred for bulk testing)
• Point-of-Care (POC) HbA1c Devices (fastest CAGR >11% through 2030)
By Technology
• Ion-exchange High-Performance Liquid Chromatography (HPLC) (most accurate, gold standard)
• Immunoassay
• Boronate Affinity Chromatography
• Direct Enzymatic Assay
• Other Emerging Technologies
By End User
• Hospitals & Clinics
• Diagnostic Laboratories
• Physician Offices
• Home Care Settings (rising sharply due to consumer-friendly test kits)
Growth Highlights
• Ion-exchange HPLC accounts for the largest share due to precision and reliability.
• POC analyzers expected to nearly double their market share by 2030.
• Home testing segment growing due to telehealth and remote diabetes monitoring trends.
Recent Developments
• Abbott Laboratories enhanced its Alinity systems with high-throughput HbA1c testing modules.
• Roche Diagnostics released workflow automation tools improving lab productivity and result accuracy.
• Siemens Healthineers rolled out refined enzymatic HbA1c assays with faster turnaround times.
• ARKRAY launched portable analyzers designed for rural and decentralized diabetes care.
• Bio-Rad Laboratories upgraded chromatographic analyzers to deliver superior accuracy in clinical labs.
Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=73489
Expert Quote
"With diabetes projected to rise by 25% over the next decade, dependable HbA1c testing has become a global necessity. The shift toward point-of-care and automated systems is creating new opportunities for healthcare providers to deliver faster and more accurate diabetes management."
-Irfan Tamboli, Business Development Executive, Exactitude Consultancy
Market Drivers
• Sharp rise in Type 1 & Type 2 diabetes cases worldwide
• Growth of preventive healthcare and routine screenings
• Strong shift toward point-of-care diagnostic technology
• Increasing government-backed diabetes control programs
• Integration of AI, automation, and digital connectivity into analyzers
• Expanding geriatric population needing continuous monitoring
Forecast Outlook
The market is expected to grow steadily toward USD 3.10 billion by 2030, supported by innovations in rapid testing, compact analyzers, and remote monitoring tools. Asia-Pacific remains the fastest-growing region, driven by large diabetic populations and improving healthcare accessibility. North America and Europe continue to lead in technology adoption and reimbursement support.
Government & Regulatory Initiatives
• Global diabetes control programs from public health bodies and ministries
• Increased insurance coverage for HbA1c tests in multiple countries
• Accelerated regulatory approvals for advanced HbA1c analyzers
• National screening policies boosting test penetration in rural areas
Conclusion
The Glycated Haemoglobin Testing Market is positioned for strong growth through 2030, supported by clinical demand, device innovation, government initiatives, and expanding diagnostic infrastructure. Companies that invest in automation, point-of-care technology, and digital integration will achieve the strongest competitive advantage.
This report is also available in the following languages : Japanese (グリコヘモグロビン検査市場), Korean (당화혈색소 검사 시장), Chinese (糖化血红蛋白检测市场), French (Marché des tests d'hémoglobine glyquée), German (Markt für glykiertes Hämoglobin (HbA1c)), and Italian (Mercato dei test dell'emoglobina glicata), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/73489
Our More Reports:
Novel Spectrometry Market
https://exactitudeconsultancy.com/reports/73519/novel-spectrometry-market
Small Scale Bioreactors Market
https://exactitudeconsultancy.com/reports/73521/small-scale-bioreactors-market
Single Use Downstream Bioprocessing Market
https://exactitudeconsultancy.com/reports/73523/single-use-downstream-bioprocessing-market
Viral Vaccine Cell Culture Media Market
https://exactitudeconsultancy.com/reports/73525/viral-vaccine-cell-culture-media-market
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Glycated Haemoglobin Testing Market Surges to USD 3.10 Billion by 2030, growing at a CAGR of 9.2%. here
News-ID: 4294243 • Views: …
More Releases from Exactitude Consultancy
PFAS Testing Market to Reach USD 2.95 Billion by 2030,at a CAGR of 10.4%.
Sub-Headline: Rising environmental contamination, stringent government regulations, and expanding laboratory capacity are driving the PFAS Testing Market from USD 1.48 billion in 2023 to USD 2.95 billion by 2030, at a CAGR of 10.4%.
Introduction
The PFAS Testing Market is experiencing robust global growth as governments, environmental agencies, and industrial sectors intensify efforts to identify and remediate contamination caused by per- and polyfluoroalkyl substances (PFAS). Known as "forever chemicals," PFAS compounds persist…
Drug Delivery Systems Market Key Innovations Drive 2025-2035 Outlook
Introduction
The Ocular Drug Delivery Systems Market is entering a transformative phase as the global burden of eye diseases intensifies. From glaucoma to diabetic retinopathy and age-related macular degeneration (AMD), the need for safe, targeted, and long-acting ocular therapies is rising sharply. This PR highlights the market's growth outlook, major innovations, competitive landscape, and regional trends shaping the decade ahead.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/73487
Key Takeaways
• The…
Intraocular Pressure Devices Market Poised for Strong Growth ,Key Advances from …
Introduction / Snippet
The Intraocular Pressure (IOP) Devices Market is entering a new growth phase as glaucoma becomes one of the fastest-expanding global ophthalmic concerns. With increasing cases of ocular hypertension and early-age myopia, demand for accurate, non-invasive, smart IOP monitoring tools is rising sharply. This report highlights the latest trends, growth outlook, technology shifts, and key competitive moves shaping the market from 2025 to 2035.
Download Full PDF Sample Copy of…
Alzheimer's Disease (In-68) Market Advances as Early Diagnosis, PET Imaging & Di …
Alzheimer's disease (AD) is one of the fastest-growing neurological disorders worldwide, and demand for advanced diagnostic tracers-especially 68Ga-based (In-68) PET imaging agents-is rising sharply. With early detection becoming central to effective disease management, this market is seeing significant innovation in imaging technologies, biomarker development, and targeted therapeutics. This press release covers key trends, diagnostic advancements, and the evolving landscape reshaping AD care.
Download Full PDF Sample Copy of Market Report @https://exactitudeconsultancy.com/request-sample/73641
Market…
More Releases for HbA1c
Increasing Diabetes Prevalence To Boost HbA1c Testing Demand: Transformative For …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Hemoglobin A1c (HbA1c) Testing Industry Market Size Be by 2025?
In recent times, there has been a swift expansion of the market size for Hemoglobin a1c (HbA1c) testing. The market, which was valued at $1.83 billion in 2024, is projected to rise to $2.03 billion in…
Increasing Diabetes Prevalence To Boost HbA1c Testing Demand: An Emerging Driver …
The Hemoglobin A1c (HbA1c) Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Hemoglobin A1c (HbA1c) Testing Market?
The hemoglobin A1c (HbA1c) testing market has grown rapidly in recent years. It will grow from $1.83 billion in 2024 to…
Technological Innovations in HbA1c Home Testing Trend: A Crucial Influence on th …
"What industry-specific factors are fueling the growth of the hemoglobin a1c (hba1c) testing market?
The increasing prevalence of diabetes is expected to propel the growth of the hemoglobin A1c (HbA1c) testing market. The rising cases of diabetes, fueled by poor diets and sedentary lifestyles, are driving the demand for HbA1c tests. These tests monitor long-term blood glucose control in diabetic individuals. According to The Lancet in June 2023, global diabetes cases…
Transforming the Hemoglobin A1c (HbA1c) Testing Market in 2025: Increasing Diabe …
"What Is the Expected Size and Growth Rate of the Hemoglobin A1c (HbA1c) Testing Market?
In recent years, there has been a substantial expansion in the market size for hemoglobin a1c (HbA1c) testing. The market, which was valued at $1.83 billion in 2024, is expected to increase to $2.03 billion in 2025, representing a compound annual growth rate (CAGR) of 10.7%. Factors contributing to this growth during the historical period include…
HbA1c Testing Market Insights, Forecast to 2031
"HbA1c Testing Market 2024,"
The objectives outlined in the report are multifaceted and aimed at offering a comprehensive understanding of the HbA1c Testing market dynamics. These objectives encompass a meticulous analysis and forecast of the market's dimensions, encompassing both its value and volume aspects. Additionally, the report seeks to discern and delineate the market shares held by major segments within the HbA1c Testing industry, providing stakeholders with a nuanced perspective on…
HbA1c Testing Device Market Size 2024 to 2031.
Market Overview and Report Coverage
HbA1c Testing Device Market is a medical device market that focuses on testing and monitoring the level of glycated hemoglobin in the blood, which is essential for managing diabetes. This market is driven by the increasing prevalence of diabetes worldwide, the rise in healthcare expenditure, and the growing awareness about the importance of regular HbA1c monitoring for diabetic patients.
The future outlook of the HbA1c…
